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Abstract
The genome of Saccharomyces cerevisiae is arguably the best studied eukaryotic genome, and yet, it contains approximately
1000 genes that are still relatively uncharacterized. As the majority of these ORFs have no homologs with characterized
sequence or protein structure, traditional sequence-based approaches cannot be applied to deduce their biological function.
Here, we characterize YER067W, a conserved gene of unknown function that is strongly induced in response to many stress
conditions and repressed in drug resistant yeast strains. Gene expression patterns of YER067W and its paralog YIL057C suggest
an involvement in energy metabolism. We show that yeast lacking YER067W display altered levels of reserve carbohydrates
and a growth deficiency in media that requires aerobic metabolism. Impaired mitochondrial function and overall reduction of
ergosterol content in the YER067W deleted strain explained the observed 2- and 4-fold increase in resistance to the drugs
fluconazole and amphotericin B,respectively.Cellfractionation andimmunofluorescence microscopy revealed thatYer067wis
associated with cellular membranes despite the absence of a transmembrane domain in the protein. Finally, the 1.7 A ˚
resolution crystal structure of Yer067w shows an alpha-beta fold with low similarity to known structures and a putative
functional site. YER067W’s involvement with aerobic energetic metabolism suggests the assignment of the gene name RGI1,
standing for respiratory growth induced 1. Altogether, the results shed light on a previously uncharacterized protein family
and provide basis for further studies of its apparent role in energy metabolism control and drug resistance.
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Introduction
In this work, we bring new insights into the structural and
functional characterization of a previously poorly annotated gene in
Saccharomycescerevisiae, the open reading frame(ORF) YER067W.T h i s
sequence belongs to a group of approximately 1000 genes from S.
cerevisiae (20% of the genome) that have been missed by the genome-
wide methods currently used to address protein/gene function such
as interactomes, phenotype screenings and homology-based func-
tional annotation. Like the majority of uncharacterized genes from S.
cerevisiae, YER067W codes for a short protein (#20 kDa) that is
present in duplicate in the yeast genome (shares 70% identity with the
ORF YIL057C), and its homologs are restricted to fungi and contain
no characterized functional domains [1].
The functional annotation of this subset of genes is particularly
challenging because almost nothing can be learned from sequence
comparisons. Moreover, most of the uncharacterized proteins
have no tridimensional structure available, hindering a structure-
based analysis. Functional hints are generally extracted from high-
throughput studies performed on S. cerevisiae. These data are well-
organized and accessible through the Saccharomyces Genome
Database (SGD) [2], a public database that curates the yeast
genes and also compiles Gene Ontology (GO) annotations,
publications, interactions, and a multitude of additional informa-
tion. Almost every gene has some published data compiled;
however, the information is incomplete for many ORFs to define
at least one aspect of the Gene Ontology (GO), which is
subdivided into three major branches: Molecular function,
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GO annotation awaits an experimental validation of functional
hypothesis raised from high-throughput data analysis.
YER067W attracted our attention because of its high levels of
expression in a wide range of conditions, such as intracellular iron
depletion [3], carbon source restriction [4], high temperature, high
osmotic stress, cold stress [5], unfolded protein response [6], and
high hydrostatic pressure [7]. These data point to the importance
of YER067W as a stress-related gene in non-standard laboratory
growth conditions.
Another notable feature of YER067W gene regulation concerns
its apparent correlation with the development of a drug-resistant
phenotype in yeast. A study of S. cerevisiae showed that cells
chronically treated with different antifungal drugs from the azole
class display a consistent down-regulation of YER067W [8].
Furthermore, two other independent works that employed
microarray analysis to address differences in gene expression
between fluconazole-resistant and -susceptible strains showed that
both YER067W and its Candida albicans ortholog IPF20056 (ORF
191354) are repressed in the fluconazole-resistant strain. This trait
was observed in an experimentally induced resistant strain of S.
cerevisiae that was selected for fluconazole tolerance after growth for
400 generations in the presence of the drug [9] and was also
observed in three different clinical isolates of Candida albicans that
developed fluconazole resistance [10]. Fungal infections are
particularly complex to treat because there are few classes of
antifungal drugs available and the repetition and lengthy duration
of treatment favors the development of drug-resistant strains [11].
The most widely used drugs belong to the azole class, which
inhibit the enzyme lanosterol demethylase (Erg11), involved in the
ergosterol biosynthetic pathway. Ergosterol is also the target for
polyene drugs such as amphothericin B and nystatin. As both
classes of drugs act on components of the same pathway, the
mechanisms of resistance developed against one kind of drug are
frequently effective against the other. Moreover, due to the
similarity of the cellular machinery of fungi and metazoans, it is
difficult to develop fungal-specific drugs [12]. Therefore, the
characterization of new fungal-specific proteins involved in the
development of drug resistance is of outstanding interest.
Despite the notable induction of YER067W in several
environmental conditions, very little data concerning protein-
protein or genetic interaction is available for Yer067w. Two-
hybrid experiments and mass spectrometry-based identification of
Yer067w interaction partners offer some potential hits, but they
are never confirmed within the experiment (no more than a single
identification event) or between experiments (coincident hits in
different experiments) [13,14]. Moreover, the putative interaction
partners are of very diverse functions and have promiscuous
interaction profiles; for example, Rpp0, a ribosomal protein that
was identified as a putative Yer067w interaction partner, appears
to be physically associated to more than 100 proteins of varied
functions [14].
The only GO annotation available for Yer067w comes from a
genome-wide localization study using GFP-tagged proteins and
points to a nuclear and cytoplasmic localization for Yer067w
during normal growth conditions [15].
In this work, we use existing gene regulation data and apply
different experimental methodologies to improve the functional
annotation of YER067W. We determine whether YER067W is
adaptively important to S. cerevisiae and uncover the biological
processes in which this stress-induced protein plays a role,
including confirmation of the drug-resistance connection suggested
by gene regulation data. We more accurately determine the
cellular distribution of this protein by observing the localization of
an untagged Yer067w protein. Finally, we present the three-
dimensional structure of Yer067w and determine whether it
resembles any previously characterized folds.
Results and Discussion
Phylogenetic analysis reveals that Yer067w is under
strong selective constraint
To identify Yer067w homologs, we performed BLAST and PSI-
BLAST similarity searches using the Yer067w protein sequence to
query the non-redundant protein database (NCBI). Despite the
enhanced sensitivity of PSI-BLAST in searches for distantly-
related proteins [16], both programs retrieved the same proteins,
including the S. cerevisiae paralog Yil057c and orthologs from
different fungal genera (Candida, Pichia, Ashbya, Kluyveromyces,
Lodderomyces, Debaryomyces, and Vanderwaltozyma). The search was
completed by exploring the Fungal Orthogroups Repository [17],
which retrieved homologs from other Saccharomyces and Candida
species (Figure 1). This analysis clearly showed that the 23 proteins
homologous to Yer067w are restricted to ascomycetes belonging to
the Saccharomycotina subphyla. A sequence alignment of the
Yer067w family (Figure 1) reveals a high degree of conservation
throughout the Saccharomycotina. A significant fraction of
positions are identical in 50% or more of Yer067w family
members (asterisks) and more than 20 positions are identical
amongst all family members (green boxes). The limited phylogenic
distribution of Yer067w homologs is characteristic of orthologous
‘‘ORFans’’, genes that are typically present in only a few, generally
closely related organisms and have no annotated function [18].
Many orphan genes demonstrate a higher evolving rate than
non-orphan genes, changing so quickly that sequence similarity
cannot be traced beyond a certain evolutionary distance. This
trend suggests that those genes are under low selective pressure
and perform accessory or redundant functions [19]. To evaluate if
this would be the case for YER067W, we analyzed the evolution
rate of this gene and examined the phylogenetic history of
Yer067w protein family.
Evolution rate can be inferred from the ratio of the number of
non-synonymous substitutions per non-synonymous site (dN) to
the number of synonymous substitutions per synonymous site (dS),
a measure that distinguishes the amino acid selection pressure
from the background nucleotide mutation rate [20]. In a previous
work analyzing dN/dS ratio in four closely related yeast species (S.
cerevisiae, S. mikatae, S. bayanus, and S. paradoxus), the dN/dS ratio for
YER067W was 0.03, indicating a relatively slow mutation rate
given that the whole genome mean for dN/dS ratios in S. cerevisiae
was 0.10 [21]. This analysis indicates that the YER067W locus is
under strong selective constraint and that it is not a quickly
evolving gene.
Moreover, the phylogenetic tree constructed using YER067W
homologs (Figure S1) closely resembles the evolutionary history of
the Saccharomycotina subphyla [22], reinforcing the conservation
of this gene family. Another interesting feature of the YER067W
family is the presence of a duplicated pair of homologs in almost
every species that diverged after a whole genome duplication
(WGD) event [22]. The conservation of both genes in WGD yeast
species is a remarkable feature because nearly 90% of the
duplicated genes in yeast genomes have lost one member of the
pair in the present-day set [23]. Because truly redundant genes are
unlikely to exist, the presence of two copies may be explained by a
neofunctionalization, in which one duplicate evolves a useful new
function while the other one performs the ancestral function, or a
subfunctionalization, in which the duplicates partition ancestral
functions between themselves so that both duplicates are required
Yer067w Structure and Ontology
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differently expressed or localized within the cell). In the following
sections, this question will be addressed by analyzing gene
expression regulation and phenotypes associated with deletion of
YER067W and its paralog YIL057C.
YER067W and YIL057C display different induction
patterns linked to genes involved in energy metabolism
Analysis of global gene expression in several environmental
conditions revealed an interesting feature of genome regulation:
genes involved in common pathways or metabolic processes tend
to be coordinately expressed/repressed. Therefore, the functions
of characterized genes in a given regulatory cluster can suggest
hypothetical functions for uncharacterized genes in the same
cluster [5]. As YER067W expression is affected by a wide range of
conditions, this approach can identify in which aspects of yeast
physiology YER067W is involved.
By comparing several data sets from microarray experiments
using the program SPELL [24], we verified that the expression of
the YER067W gene is tightly linked to genes involved in
carbohydrate metabolic processes (p value =5.22 10
25), including
glycogen synthases (GSY1 and GSY2) and trehalose synthase
subunits (TPS2 and TSL1) (Table S1). However, the paralog
YIL057C is mainly co-regulated with genes that are involved in
lipid oxidation in the peroxisome such as PXA1, CTA1, POT1 and
ECI1 (p-value of 5.9510
23) (Table S1).
These results are corroborated by the differences in the promoter
structuresof YER067WandYIL057Casdetermined bythe program
Yeastract(Table S2)[25].TheYER067Wpromotercontainsseveral
binding sites for the stress response transcription factors Msn2/4
and Hsf1, and these sites have been functionally validated [5,26].
Transcriptional control of YER067W by the main stress-responsive
gene activators of Saccharomyces cerevisiae explains the wide range of
conditions in which expressionof this gene is induced. However, the
co-regulation of YER067W with metabolism-related genes and not
heat-shock proteins, which are involved with protein homeostasis,
suggests that YER067W is mainly implicated in energetic metab-
olism adjustments in response to adverse conditions.
Conversely, YIL057C does not possess stress response elements
such as Msn2/4 or Hsf1 in the promoter region (Table S2);
instead, its induction seems to be governed by Adr1, a
transcription factor that activates genes involved in the utilization
Figure 1. Sequence alignment of 23 proteins homologous to Yer067w protein. Sequences were identified by a PSI-BLAST search against
the NR protein database and against the Fungal Orthogroups Repository [17]. Sequences are indicated with abbreviations corresponding to the
species of origin, the gene identification code, and the protein amino acid number. The species and NCBI accession number, when available, are as
follows: Scer, Saccharomyces cerevisiae, YER067W, NP_010990.1, YIL057C, NP_012207.1; Agos, Ashbya gossypii, ADL065Wp, NP_984031.1; Scas,
Saccharomyces castelli; Klac, Kluyveromyces lactis, KLLA0C08063g, XP_452559.1; Sbay, Saccharomyces bayanus; Smik, Saccharomyces mikatae; Spar,
Saccharomyces paradoxus; Kwal, Kluyveromyces waltii; Cgla, Candida glabrata, CAGL0J03080g, XP_447838.1, CAGL0M12551g, XP_449888.1; Vpoly,
Vanderwaltozyma (Kluyveromyces) polysporus, Kpol_411p18, XP_001642931.1h; Clus, Candida lusitaniae; Dhan, Debaryomyces hansenii, DEHA0D04532g,
XP_458633.1; Cgui, Candida guilliermondii, PGUG_01560, XP_001485889.1; Pstip, Pichia stipitis, PICST_83546, XP_001384498.1; Lelong, Lodderomyces
elongosporus, XP_001526050.1; Ctro, Candida tropicali; and Calb, Candida albicans, CaO19.8934, XP_710246.1. Positions that are invariant across all
species are highlighted by green boxes, and positions at which 50% or more sequences have identical residues are indicated by asterisks.
doi:10.1371/journal.pone.0011163.g001
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genes [27]. This observation is in agreement with YIL057C up-
regulation in situations that require aerobic energetic metabolism
pathways [28–30] and is in accordance with the SPELL results
(Table S1).
YER067W and YIL057C are important for cell growth in
non-fermentable carbon sources
To test if the data from global transcriptional analyses correlate
with expression at the protein level, we examined the expression of
TAP-tagged versions of YER067W or YIL057C genes in different
growth conditions (Figure 2A). Yer067w was expressed in the
presence of glucose and showed high levels of expression after heat
shock at 37uC for 1 hour and when grown in glycerol, a
respiratory carbon source. However, Yil057c signal was barely
detectable during glucose growth and after heat shock but was
clearly induced in the presence of glycerol (Figure 2A).
The strong correlation between Yil057c and Yer067w expres-
sion in the presence of non-fermentative substrates prompted us to
test whether the BYDyer067w and BYDyil057c deletion mutant
strains would present any fitness defect when grown in these type
of carbon sources (Figure 2B). The mutant strains exhibited
normal growth in fermentative substrates such as glucose and
galactose but were clearly deficient in media containing glycerol
and ethanol, in which oxidative phosphorylation is necessary to
fully metabolize these substrates (Figure 2B). The BYDyer067w
strain displayed a growth delay when compared to the parental
strain BY4741, while BYDyil057c exhibited a more intense
phenotype. These results correlate well with the specific induction
of YIL057C in low glucose media (Figure 2A). The double mutant
BYDyer067wDyil057c displayed a phenotype similar to BY-
Dyil057c. This kind of genetic interaction, in which the double
mutant is as viable as any of the single mutants, usually indicates
that the pair of proteins belongs to the same complex and/or
operates in the same pathway [31]. However, the clear phenotype
observed in both single mutants suggested that, despite the high
degree of similarity, these ORFs may perform analogous but not
fully redundant functions. Therefore, the maintenance of this pair
of duplicated genes may be due to subfunctionalization of each
copy.
Interestingly, neither BYDyer067w nor BYDyil057c differed
from the wild type strain (WT) in growth in glucose-containing
media at 37uC (Figure 2B). Furthermore, the mutations did not
affect cell survival after high hydrostatic pressure treatment (data
not shown), another stress condition that leads to YER067W gene
induction [7].
As a next step, we quantified the intracellular content of
glycogen in the mutant strains. Figure 2C shows the glycogen
content in yeast cells at mid-log and stationary phases. In
agreement with a previous screen for mutations that disturb
glycogen metabolism [32], deletion of YIL057C leads to an
enhanced glycogen accumulation in growing cells, while deletion
of YER067W shows no phenotype in this situation. However, in
the stationary phase, when glycogen synthesis is favored even in
WT cells [33], all mutants clearly display a glycogen over-
production phenotype in comparison to BY4741. S. cerevisiae cells
store glucose as glycogen and also as trehalose [33]. To verify if the
mutations were specifically affecting glycogen metabolism, we
determined the trehalose content of cells from each strain.
Trehalose was over-produced in the strain lacking Yer067w and,
to a lesser extent, Yil057c (Figure 2C), suggesting that the lack of
these proteins induce a metabolism shift toward the accumulation
of reserve carbohydrates upon starvation.
Altogether, these results show that both the Yer067w and
Yil057c proteins are involved in the control of energetic
metabolism and significantly contribute to cell fitness, especially
under respiratory growth conditions. These data assist in
assignment of biological process for both ORFs in the Saccharomyces
Genome Database (SGD). Furthermore, based on our experi-
mental data, we propose the gene names RGI1 and RGI2, as in
Figure 2. Protein expression analysis and phenotypes associ-
ated with the deletion of the YER067W gene. (A) Western blot of S.
cerevisiae strain BY4741 harboring either YER067W or YIL057C genes
fused to the TAP-tag reveals that these proteins are differently
regulated. Cells were grown on glucose to the first log phase (Glu),
heat shocked at 37uC for one hour (37uC) and grown on glycerol (Gly).
The specific signal was revealed using anti-TAP antibody. As a loading
control (Load), the PVDF membrane was stained with Coomassie-blue
R. (B) Qualitative growth assay comparing cell growth of yeast strains
deleted for YER067W, YIL057C or both and the wild type strain BY4741
grown in different media. Cells were grown to stationary phase and
normalized to 10
7 cells/mL. Serial dilutions of the suspension were
spotted onto YP supplemented with 2% of glucose (Glu), galactose
(Gal), glycerol (Gly) or ethanol (EtOH). All plates were grown for 28uCo r
37uC for 48 hours and then photographed. Figure 2B corresponds to
the third dilution step. (C) Quantification of intracellular levels of
glycogen and trehalose of strains BY4741, BYDyer067w, BYDyil057c and
the double mutant grown in YPD to either mid-log or stationary phase.
Error bars indicate standard deviation from three independent
experiments. The significant difference between each mutant and
BY4741 is denoted with an asterisk (P,0.05 T-test).
doi:10.1371/journal.pone.0011163.g002
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YIL057C, respectively.
YER067W deletion enhances S. cerevisiae tolerance to
fluconazole and amphotericin B
To follow up on earlier reports of Yer067w’s role in drug
resistance, we tested whether the strains lacking Yer067w would
display a drug-resistance phenotype, as was suggested by the
down-regulation of this gene in fluconazole-resistant strains [9,10].
Cells were serially diluted and spotted on plain YPD plates and
YPD plates containing 1.0 mg/mL amphotericin B or 16.0 mg/mL
fluconazole (Figure 3A). In the presence of both drugs, cell colonies
from BYDyer067w and the double mutant could be detected in
dilutions steps in which BY4741 and BYDyil057c were no longer
able to grow. This result points to an enhanced antifungal drug
tolerance induced by YER067W deletion.
The resistance level was further evaluated by Minimal
Inhibitory Concentration (MIC) determination using the micro-
dilution method (Figure 3B). YER067W deletion promoted a slight
increase in fluconazole tolerance. The MIC50 for BYDyer067w
and the double mutant was 8 mg/ml, while the values for BY4741
and BYDyil057c were around 4 mg/ml. The protective effect of
Yer067w deletion against treatment with the cytotoxic drug
amphotericin B was stronger than observed for fluconazole, with a
increase of at least 4 times when compared to the wild type strain
(Figure 3B).
Classically, resistance to polyenes and azoles is achieved by an
increase in the expression of multidrug transporters in the plasma
membrane or modulation of the ergosterol metabolism genes [12].
Additionally, the petite phenotype, observed in cells lacking
mitochondrial DNA (Rho-) and therefore, unable to respire, is
associated with fluconazole resistance in different yeast species
[34,35].
No differences in drug resistance between BY4741 and the
mutants were evident when yeast cells were grown in the presence
of cycloheximide, a drug that blocks protein synthesis (data not
shown). This observation indicates that the resistance conferred by
a YER067W deletion is not due to a general effect, as expected for
an over-expression of multidrug transport proteins, but is
specifically related to anti-fungal drugs targeting the ergosterol
metabolism. Therefore, we compared the sterol content of
BYDyer067w and WT (Figure 4A). Even though the same
biosynthetic intermediates were found in both cell populations
after separating different sterol species using gas mass chromatog-
raphy, a consistent reduction of 46.0% of the ergosterol
(SD65.0%, four independent analysis) content in BYDyer067w
was observed (Figure 4A, peak 2).
Moreover, BYDyer067w oxygen consumption was analyzed
using a high-resolution oxygraphic system (Figure 4B and C). In
agreement with the growth defect under non-fermentable carbon
sources, cells lacking YER067W consumed approximately 50% less
oxygen in comparison to WT (Figure 4B). Interestingly, the
mutant cells oxygen consumption was insensitive to the addition of
oligomycin, a drug that blocks the proton channel of the
mitochondrial ATP synthase, leading to a reduction in oxygen
consumption, and also FCCP, an ionophore that uncouples the
oxidative phosphorylation from ATP synthesis and results in
enhanced oxygen consumption. These results suggest that
mitochondrial physiology is also affected by deletion of YER067W.
The overall reduction of ergosterol synthesis in BYDyer067w
could diminish the accumulation rate of the toxic intermediate 14
a-methylfecosterol upon ERG11 inhibition by azoles and could
reduce polyene binding to the membrane. This possibility could
explain the resistance observed in the presence of both fluconazole
and amphotericin B. However, the apparent mitochondrial
dysfunction can also account for the resistance, as has been
Figure 3. Fluconazol and amphotericin B susceptibility assay of yeast cells deleted for YER067W or YIL057C or both genes in
comparison to the parental strain. (A) Qualitative assay showing BYDYer067w drug resistance phenotype. Cells were grown up to the stationary
phase and normalized to 10
7 cells/mL. Serial dilutions of the suspension were spotted onto YPD (control) or YPD containing 16.0 mg/mL of fluconazol
and 1.0 mg/mL of amphotericin B. Plates were incubated for 48 hours at 28uC, and then photographed. (B) For a quantitative drug resistance analysis,
yeast cells were grown in increasing drug concentration for 16 hours, at which point the OD600nm was determined. Complete (100%) growth was
defined by the OD reached by the drug-free control for each strain. Standard errors are smaller than the graph symbols.
doi:10.1371/journal.pone.0011163.g003
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[34,36].
It is known that the ergosterol and aerobic metabolism are
tightly linked, but the mechanisms underlying this connection are
not well established. For example, yeast cells deficient in ergosterol
biosynthesis are known to display aberrant mitochondrial
morphology and impaired respiration [28]. The reverse is also
true: cells with mitochondrial defects show modulation in
ergosterol gene expression and their sterol profile [34]. Presently,
we cannot distinguish between these possibilities in relation to our
results.
It is also important to note that the increase in drug resistance
promoted by YER067W deletion alone is modest in comparison to
the MICs of the resistant strains of S. cerevisiae or C. albicans, in which
down-regulation of this gene was observed [8–10]. However, those
strains all possess mutations in ergosterol biosynthesis genes or
exhibit over-expression of multidrug transporters, alterations that
arefrequentlyassociatedwithhighdegreesofdrugresistance.Inthis
scenario, it seems that YER067W suppression is an adaptive event
that favors the fixation of a drug tolerance phenotype by inducing a
series of metabolic alterations that help support growth in the
presence of azoles and polyenes.
Yer067w is associated with membranes
Cellular component is another aspect of the GO description and
refers to the protein localization within the cell. The data available
for Yer067w were obtained in a global study using a library of
GFP-tagged S. cerevisiae strains [15]. To revise this information, we
developed a polyclonal antibody specific to Yer067w (no cross
reaction with Yil057c, data not shown) that was raised against the
purified full-length Yer067w expressed in Escherichia coli. This new
tool dispenses the need to tag an 18.9 kDa protein with larger GFP
(26.9 kDa) or TAP–tag (20.2 kDa) and, therefore, prevents the risk
of protein mislocalization.
As a first approach to confirm the cytoplasmic and nuclear
localization previously suggested for Yer067w [15], we performed
a differential centrifugation cell fractionation experiment.
Figure 5A shows the partition of Yer067w within the centrifuga-
tion steps using western blot analysis. As a control, we also
analyzed the fractionation pattern of proteins known to localize in
the cytoplasm (actin, Act1) and membranes (plasma membranes
proton-ATPase, Pma1 and the multidrug transporter, Pdr5).
Unexpectedly, Yer067w was concentrated in the 100,000 g
sedimented fraction (P2) and, to a lesser extent, in the 12,000 g
sediment (P1). Almost no signal could be detected in the cytoplasm
(Snt, soluble fraction). The P1 fraction is enriched in moderately
dense organelles, such as mitochondria and peroxisomes, and also
contains plasma membrane fragments. The P2 fraction concen-
trates the low density Golgi vesicles, secretory vesicles and plasma
membrane [37]. The Yer067w sedimentation pattern was the
same observed for membrane bound proteins Pdr5 and Pma1, but
not for Act1, which was mainly present in the soluble fraction.
This result was not due to Yer067w protein aggregation and
precipitation in the fractioning buffer because the recombinant
Yer067w was fully soluble after 100,000 g centrifugation in this
buffer condition (not shown).
To confirm the Yer067w association to membranes, localization
was also checked by indirect immunofluorescence microscopy
(Figure 5B). We observed a peripheral signal with a punctuate
pattern, suggesting a possible lipid raft association. As the primary
sequence indicates that Yer067w is a relatively charged protein
with no transmembrane domains, it is possible that the interaction
is driven by interactions with yet unidentified membrane-bound
protein or via electrostatic interactions with membrane lipids. This
localization profile clearly conflicts with the GFP data from
Ghaemmaghami, et al [14] and adds a new perspective to
Yer067w characterization.
Figure 4. Analysis of the sterol composition and oxygen
consumption of yeast cells deleted for YER067W gene. (A) The
accumulation profile of GC sterols for BY4741 and BYDyer067w. Peak 1,
cholesterol (exogenous standard); peak 2, ergosterol; peak 3, fecosterol;
and peak 4, lanosterol. Note that BYDyer067w shows a reduced content
of ergosterol (46%65.0% four idependent extractions) indicating a
down regulation in ergosterol synthetic pathway (B) Oxygen consump-
tion rates of yeast cells growing in glycerol reveal an impaired
respiratory metabolism in BYDyer067w. (C) Relative changes in oxygen
consumption rate caused by sequential addition of 5 mg/mL of
oligomycin and 1 mM of FCCP. BYDyer067w insensitivity to the drugs
tested suggests that mitochondrial physiology is affected by the
absence of YER067W protein. Asterisks indicate a significant difference
from BY4741 (P,0.05 T-test).
doi:10.1371/journal.pone.0011163.g004
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a conserved putative functional site
Because proteins from the Yer067w family lie beyond homology
modeling distance from any other protein with known structure or
function, the structural study of Yer067w may provide valuable
information for the functional characterization of this group. The
initial crystallization trials with thefulllength recombinantYer067w
produced small, poorlydiffracting, two-dimensional crystals,despite
the good overall fold observed in the 2D [
1H-
15N] HSQC spectra
(Figure S2). It is likely that the crystal formation was hindered by a
highly charged, flexible N-terminus (Figure 1). Therefore, we
designed a shorter construct of Yer067w, named 11V-161NYer067w,
by removing ten N-terminal residues (1MTKKDKKEVK10). The
NMR analysis of the truncated protein resulted in the same pattern
of chemical shifts compared to the full-length Yer067w, indicating
that the overall structure remained intact (Figure S2). High-quality
crystals of 11V-161NYer067w were obtained allowing the determina-
tion of structure to 1.7 A ˚ resolution using the multi-wavelength
anomalous dispersion (MAD) method. Data collection and
refinement statistics for 11V-161NYer067w are summarized in
Table 1.
The structure reveals an a/b topology with a seven-stranded
mixed b-sheet backed by four a-helices on one side (Figure 6A).
The overall structure is compact and relatively rigid, in which the
highest B-factor values, which reflect the fluctuation of atoms
about their average positions in crystal structures, correspond to
the N-terminal residues including the b1 strand (E17-D18).
Notably, the first five residues of the construct (11VQTVT15)
are disordered in the crystal. The secondary structure elements
are arranged in the b1-b2-a1-b3-a2-a3-a4-b4-b5-b6-b7 order
(Figure 6B). The slightly twisted b-sheet is formed by antiparallel
strands, except for the b2-b3 pair, which is parallel. The short b2
strand connects to b3 through the helix a1, while b3 is followed by
the cluster of helices a2, a3 and a4 before giving rise to the strand
b4. The rest of the b-sheet is connected by short b-turns. The
amphipathic helices a1 (L28-E40) and a4 (S77-V100) pack against
the b-sheet, while the short a2 and a3 helices are projected
outwards from the b-sheet surface. The longest helix, a4,
transversally crosses the b-sheet and is mainly stabilized by
hydrophobic interactions involving the nonpolar amino acids F80,
L84, I88, L92, I96, and V100 that are facing the inner face of the
b-sheet. Interestingly, this helix contains an unusual bulge in the
fourth turn. The origin of this bulge is probably induced by the
shift in hydrophobic periodicity, such that the E89-K90-H91
stretch is sandwiched between the H87-I88 and L92-L93 residues
in the hydrophobic core. The side chain of H87 is stabilized in the
hydrophobic core by a salt bridge with the side chain of Y53. The
bulge is partially stabilized by a hydrogen bond between carbonyl
of K90 and the side chain of K94 via an ordered water molecule.
The surface of the protein is abundant in negatively charged
residues (Figure 7B). The main exception is the patch of positively
charged residues centered on the helix a4.
Analysis of crystal packing reveals that Yer067w forms a dimer
in the crystal. The strands b4 of each monomer align into an
antiparallel b-sheet to yield a continuous fourteen-strand b-sheet
in the Yer067w dimer. The protein is unlikely to form a stable
dimer in solution because the dimeric arrangement is not
stabilized by any other intermolecular interactions besides the
backbone hydrogen bonds. The biological relevance, if any, of the
crystallization-produced Yer067w dimer remains to be seen.
To identify potential functional sites of Yer067w, we analyzed
the location of residues conserved throughout the Yer067w family
in the Yer067w structure (Figure 7A). Some of the strictly
conserved Yer067w residues (F25, F31, F57, I69, L84, L92, W121,
and V149) are buried in the structure and are important for
structural stability. The most prominent patch of invariant surface
residues is located in a cavity at the junction of all four helices
(Figure 7A). It includes the invariant 53YYPPF57 stretch, which
may be important to keep the shape of the cavity intact. The
surface also contains two invariant histidines H87 and H91, amino
acids that are frequently encountered in active sites of various
enzymes [38]. However, these histidines are unlikely to be
involved in catalytic activity because they are not neighbored by
glutamates/aspartates that usually contribute to acid-base enzy-
matic mechanisms. However, the conserved cavity is long and has
a largely hydrophobic character, hinting at the large size of the
ligand and suggesting that this cavity is likely to be a protein-
binding site. Even though not a part of the structured domain, the
mobile N-terminus is positively charged due to a presence of
multiple lysine residues and could present an interaction site with
phospholipids.
To gather more clues about Yer067w’s function, we searched for
structural homologs of Yer067w using the DALI [39]and SSM[40]
programs. Yer067w displays an overall two-layer a/b fold that is
quite common, corresponding to the second most populated fold
group among a/b proteins [41]. Nevertheless, both programs
indicated that Yer067w shares only weak structural homology with
a number of a/b structures (Figure 8 B). The best hit corresponds to
Figure 5. Localization analysis of Yer067w. (A) Western blot
analysis of cell fractionation by differential centrifugation reveals that
Yer067w is localized in cell membranes. Total protein extract was
obtained from BY4741 grown overnight in glycerol. Tot, total protein
extract; P1, fraction sedimented after 12,000 g centrifugation; P2,
fraction sedimented after 100,000 g centrifugation; and Snt, soluble
fraction collected from 100,000 g centrifugation step. (B) Immunolo-
calization of Yer067w. Images were collected from wild type BY4741
and the BYDyer067w strain. Yer067w specific signal was visualized
using anti-Yer067w primary antibody and 488-ALEXA conjugated
secondary antibodies. DAPI-stained DNA (blue) signals and Nomarski
(DIC) images were also recorded. The exposure time used for image
acquisition was equal for both strains.
doi:10.1371/journal.pone.0011163.g005
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code 1tu1), presenting a DALI Z-score of 5.9 (Z-scores below 2 are
structurally dissimilar) and SSM Q-score of 0.17 (Q =1 means
exact structural alignment) (Figure 8B). Despite the low scores
obtained for theseputative structural homologs,eachof the matches
was analyzed to identify key residues or structural motifs resembling
the conserved core of the Yer067w family. However, the structural
superpositions were driven almost exclusively by similarities among
b-sheets, showing no resemblance to the conserved core around the
junction of a-helices that is characteristic of the Yer067w family
(Figure 8). Additionally, the Yer067w structure was refractory to
functional predictions of the ProFunc server [42], despite the
combination of different functional assignment approaches that
included identification of smaller sub-motifs (e.g., helix-turn-helix,
DNA binding patterns) and highly specific n-residue template
methods (enzyme active sites, binding sites, DNA-binding residues
and reverse template analysis).
The Yer067w fold could not be automatically classified into any
of the a/b architectures/topologies using the program CATHE-
DRAL, as all matches showed sequence identity below 35% and
an SSAP score below 80 [43]. The best scores (SSAP ranging from
70–74 and identity ,10%) suggested several possible classifica-
tions, including Roll architecture, as in Nuclear transport factor
(NTF)-like proteins (Figure 8 C, D) and a two-layer sandwich
architecture (Figure 8F). The Yer067w structure differs from the
NTF fold in two main aspects. While the NTF fold is characterized
by a highly curved b-sheet flanked by a-helices forming a conical
structure [44], the Yer067w b-sheet is only slightly twisted,
forming a supporting surface for the a-helices rather than a roll-
like structure. Furthermore, the C-terminal helix a4 of Yer067w is
structurally aligned to the N-terminal helix a1 of NTF-like
proteins, underlining the distinct topology among these proteins.
The other possible classification is a two-layer sandwich
architecture represented by the TATA-binding protein (PDB code
1qna), which agrees well with the overall fold of Yer067w: a b-
sheet backed by a-helices on one side. However, we could not find
any structures in the CATH database with the same order and
configuration of secondary structure elements as those of
Yer067w, precluding a straightforward classification in any of
the topologies already classified as the two-layer sandwich
architecture. Thus, the Yer067w structure likely defines a new
subfamily of the a/b proteins, contributing to our understanding
of the protein-fold space and the relationship between sequence
and three-dimensional structure.
To complete the structural characterization of the Yer067w
family, we modeled the three-dimensional structures of selected
representatives from distinct phylogenetic branches using the
program SwissModel with the Yer067w structure as a template
(Figure 8G, H). The model of DEHA0D04532 from Debaromyces
hansenii, the most distant Yer067w homolog, is highly similar to the
Table 1. Data collection and refinement statistics.
Data collection
Space group P43212
Cell dimensions
a, b, c (A ˚) 41.2, 41.2, 184.4
Peak Inflection High Remote Low Remote
Wavelength 0.9790 0.9794 0.9642 0.9951
Resolution (A ˚) 50–1.61 (1.67–1.61)
a 50–1.60 (1.66–1.60) 50–1.60 (1.66–1.60) 50–1.60 (1.66–1.60)
Rmerge 0.066 (0.112) 0.063 (0.106) 0.063 (0.117) 0.068 (0.150)
I/sI 32.6 (7.4) 32.2 (7.1) 32.2 (6.9) 31.1 (4.5)
Completeness (%) 92.3 (55.4) 91.3 (50.9) 93.5 (60.6) 88.9 (40.7)
Redundancy 6.5 (1.7) 6.4 (1.6) 6.6 (1.8) 6.4 (1.5)
Refinement
Resolution (A ˚) 19.5–1.70
No. reflections 17,490
Rwork/Rfree 0.196/0.238
No. atoms
Protein 1221
Water 155
B-factors
Protein 7.4
Water 21.2
R.m.s deviations
Bond lengths (A ˚) 0.013
Bond angles (u) 1.37
Ramachandran plot % of
residues in most favorable regions
90.2
Additional allowed regions 9.8
aHighest resolution shell is shown in parenthesis.
doi:10.1371/journal.pone.0011163.t001
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0.3 A ˚, as calculated by SSM pairwise comparison (Figure 8G).
The most obvious difference in the DEHA0D04532 model is an
insertion between strands b5 and b6 that is predicted to form two
short b-strands in the model. The structural models of the proteins
from the post-WGD species are highly similar to the Yer067w
structure, which reflects the high sequence identity between these
proteins. For example, the structural model of Yil057c is nearly
identical to that of Yer067w, with a Q-score of 1 and an RMSD of
0.06 A ˚ (Figure 8H). Similar results were obtained for homologs of
Ashbya or Candida (data not shown). These results suggest that the
three-dimensional structure of the Yer067w family has undergone
very minor changes over almost 170 million years, when the CTG
group diverged from the Saccharomycotina complex [22]. These
data point to a conserved functional role for this protein that was
well-preserved during evolution.
Our phylogenetic analysis suggests that YER067W belongs to a
class of genes that are particularly interesting for studying the
genetics of evolutionary divergence, the slowly evolving orphan
genes. These genes can be viewed as signatures of genetic
pathways that have been newly acquired in a particular lineage
and are of special importance for the respective lineage [45].
Additionally, the functional evidence points to an involvement
of Yer067w in the oxidative activity of yeast that is coupled to
ergosterol metabolism. The decrease in both parameters is
associated with drug resistance, a phenomenon that is of both
economical and medical interest, considering the presence of
Yer067w homologs in pathogenic yeasts such as Candida albicans
and Candida glabrata.
More than adding new information to the YER067W/RGI1
Gene Ontology, we also present the first crystal structure for this
new gene family of novel regulatory elements of aerobic energy
metabolism in Saccharomyces cerevisiae and, probably, in other fungi
species.
Materials and Methods
Alignment and phylogenetic analysis
The NCBI nr dataset was queried by BLAST and PSIBLAST
searches using the Yer067w protein sequence NP_010990.1.
Other fungal homologs were retrieved from the Orthogroups
Repository [17]. Sequences were aligned using MUSCLE [46],
and the figure was generated using JalView 2.4 [47].
Yeast strains
The following S. cerevisiae strains were used. BYYer067w-TAP
and BYYil057c-TAP containing the TAP tag introduced by
homologous recombination at the down-stream portion of the
gene. Deletion mutants BYDyer067w (MATa his3 leu2 met15 ura3
yer067w::KANMX4), BYDyil057c (MATa his3 leu2 met15 ura3
yil057c::KANMX4) and the isogenic strain BY4741 (MATa his3
leu2 met15 ura3) were obtained from Open Biosystems.
A double mutant for YER067W and YIL057C was generated as
described by Tong et al. [14], with minor modifications. Briefly, the
original selection marker KANMX4 (conferring G418 resistance) of
the strain BYDyil057c was exchanged with NATMX4 for Nourseo-
thricin (NAT) by homologous recombination upon transformation
with the plasmid pCRII-TOPO::MX4-natR. The resultant strain
BYDyil057c::NATMX4 MATa was crossed with the strain Y8205a
(MATa his3 leu2 met15 ura3 can1D::STE2pr-HIS5 lyp1D::STE3pr-
LEU2). After sporulation, haploids Mata harboring yil057c::
NATMX4 mutations were selected by the ability to grow in YPD-
NAT and in synthetic media lacking leucine. The resulting haploid
strain BYDyer057c MATa was crossed to strain BYDyer067w
MATa (Open Biosystems). Sporulation of resultant diploid cells,
followed by selection in media lacking histidine, led to the isolation of
the haploid strain BYDyer067wDyil057c MATa, harboring both the
KANMX4 and NATMX resistance cassettes. The correct insertion
of the selection markers was confirmed by PCR.
Western blotting
Cells were grown either in complete rich medium YPD
consisting of 1% yeast extract, 2% bactopeptone, supplemented
with 2% D-glucose or 2% glycerol (YPG) at 28uC. For heat shock
assay, cells grown in YPD were subjected to 37uC for one hour. At
the end of the treatments, OD600nm was determined, and the 3
units of absorbance were collected by centrifugation. Yeast cells
were resuspended in gel-loading buffer with protease inhibitor
cocktail (Roche) and submitted to two cycles of freezing/thawing
in N2 liquid followed by glass beads vortexing. Total protein
extract was resolved by SDS–polyacrylamide gel electrophoresis
(15% polyacrylamide) and electroblotted from the gel onto a
PVDF membrane using Tris–glycine buffer and then blocked
overnight in 5% (w/v) skim milk solution. The blot was probed
with the anti-TAP polyclonal antibody diluted 1:5000 (Open
Biosystems), followed by incubation with peroxidase-conjugated
1:5000 diluted antibody (Amersham, GE). The signal was detected
using the ECL Plus Western Detection Kit (Amersham, GE).
Figure 6. Crystal structure of 11V-161NYer067w protein. (A)
Ribbon diagram of Yer067w color-coded from the N-terminus (blue) to
C-terminus (red). Alpha-helices (a1-a4) and beta-strands (b1-b7) are
labeled. (B) Secondary structure elements in Yer067w superimposed on
its primary sequence. Beta and gamma-turns are denoted as b and c,
respectively. Beta-hairpins are shown as 6. The secondary structure
diagram was generated by PDBsum.
doi:10.1371/journal.pone.0011163.g006
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BY4741 (WT), BYDyer067w, BYDyer067wDyil057c were grown
in YPD up to stationary phase. Cells were normalized at a
concentration of 10
7 cells.mL
21 (OD600nm =1.0) and serially
diluted 3 times, 10-fold each step. Using a replica plate, the serial
dilutions of the suspension were patched in YP plates supplemented
with 2% glucose, 2% galactose, 2% ethanol or 2% glycerol. Plates
were incubated at 30uCo r3 7 uC for 2 days and then photographed.
All plates were made in duplicate for each treatment, and the
experiment was repeated three times.
Intracellular glycogen and trehalose quantification
The strains BY4741, ByDYer067w, ByDYil057c, ByDYer067w-
DYil057c were grown in medium YPD at 28uC until the first log
phase or stationary phase. The intracellular content of glycogen
and trehalose was determined as previously described [48]. Briefly,
50 units of absorbance (OD600nm) of yeast cells were centrifuged
and then washed two times with 1 mL of cold water. The pellet
was resuspended in 500 mL of 0.25 M Na2CO3 and boiled for one
hour for total carbohydrate extraction. Glycogen was digested by
incubating 160 mL of the suspension, previously neutralized using
40 mL of 3 M acetic acid, with 8 mL amiloglucosidase (Fluka,
75 U/mL) in 560 mL of 0.2 M sodium acetate (pH 5.2). For
trehalose determination, 40 mL of the suspension were neutralized
with 10 mL of 3 M acetic acid, and 1 mL of trehalase (Sigma
3.7 U/mL) was added along with 140 mL of 0.2 M sodium acetate
(pH 5.2). Reactions were kept at 50uC and 37uC overnight for
glycogen and trehalose digestion, respectively. Samples were then
boiled for 5 minutes to inactivate the enzymes and centrifuged.
The glucose content of 25 mL of supernatant was assayed by
adding 200 mL of glucose oxidase mixture (Glucox 500 - DOLES)
and read at 510 nm in a microplate reader apparatus. The
experiment was repeated three times.
Drug susceptibility assay
Qualitative data were generated as described in the ‘‘plate
growth assay’’ section above, with the exception that cells were
patched in YPD plates containing 16.0 mg/mL of fluconazol or
1.0 mg/mL of amphotericin B. For the quantitative assays, cells
were grown to the stationary phase in YPD medium and then
diluted to standardize the inoculums to around 1,000 cells for each
well of the 96-well microplates. Fluconazole and amphotericin B
were diluted in YPD to obtain the final working solution (2x
concentrated), which was serially diluted two times for each step,
leaving 100 mL of media in each well. After that, 100 mL of cell
suspension were added, and the cultures were allowed to grow at
28uC with agitation for 16 hours. Optical density at 600 nm was
determined using a microplate reader. The percentage of growth
relative to the drug-free control was calculated for each strain.
Experiments were independently repeated two times in triplicate
for each data point. Standard errors are smaller than the graph
symbols.
Isolation of total sterols and gas mass chromatography
analysis
BY4741 and BYDyer067w yeast cells were grown overnight at
28uC in YPD medium. Briefly, 150 units of absorbance (OD600nm)
of yeast cells were harvested by centrifugation and washed two
times with 1 mL of cold water, 10 mg of cholesterol (Sigma) was
added to the pellet as an exogenous extraction control. Total lipids
Figure 7. Position of the invariant residues of the Yer067w family in the three-dimensional structure. (A) Strictly conserved residues
shown in Figure 1 are depicted in green with the respective lateral chain in the ribbon and space-filling diagram of Yer067w. Both diagrams are
shown in the same orientation. Note the presence of a conserved cleft in Yer067w protein family. (B) Electrostatic surface charge distribution at
pH 7.5 and 150 mM NaCl was calculated by Molmol. The positive and negative regions are shown in blue and red, respectively. The conserved,
solvent-exposed residues are labeled. The first view is in the same orientation as shown in (A), while the second one shows the protein rotated
through 180u along the vertical axis.
doi:10.1371/journal.pone.0011163.g007
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under a stream of nitrogen. Total sterol content was extracted by
saponification [50]. After drying in nitrogen, sterols were
resuspended in 50 mL silylant STFA, TMCS 99:1 (Sigma-Aldrich)
+ 50 mL pyridine followed by incubation for one hour at 65uC.
GC/MS analysis was carried out on a Shimadzu GCMS-QP2010
Plus system, using an RtxH-5MS (5% phenyl 95% dimethylpoly-
siloxane), of RestekH (30 m60.25 mm60.25 mm). The injector
was set at 250uC. The column temperature was programmed from
170–250uCa t2 0 uC/min, 250–280uCa t5 uC/min and held at
280uC for 20 min. Helium was used as the carrier gas with a linear
velocity of 41.9 cm s
21. A volume of 1 mL of sample was injected
into the chromatograph. Electroionization (EI-70 eV) and a
quadrupole mass analyzer operated in scans from 50 to 700
amu. The interface was set at 230uC and the ion source at 200uC.
The components were identified by comparing their mass spectra
with those of the library NIST05 contained in the computer’s mass
spectrometer. Retention indices were also used to confirm the
identity of the peaks in the chromatogram.
Whole cells respiratory activity
Oxygen consumption by Saccharomyces cerevisiae (1610
6 cells
ml
21 grown in synthetic media supplemented with 3% glycerol)
was measured at 28uC using a high-resolution oxygraphic system
(Oroboros Oxygraph-O2K). The electrode was calibrated be-
tween 0 and 100% saturation with atmospheric oxygen, and
respiratory rates were measured under normoxic conditions. The
relative changes in oxygen consumption rate were determined
after addition of 5 mg/ml of oligomycin and 1.0 mM of carbonyl
cyanide p-trifluoromethoxyphenylhydrazone (FCCP). Experiments
were independently repeated three times for each data point.
Protein expression, preparation and purification
Residues 11-161 of S. cerevisiae Yer067w were cloned into the
pET15b vector (Amersham-Pharmacia) and expressed in E. coli
BL21(DE3) in rich (LB) medium as a N-terminal His-tag fusion.
For production of a selenomethionine-labeled protein, the
expression plasmid was transformed into the E. coli methionine
auxotroph strain DL41(DE3), and the protein was produced using
LeMaster medium [51]. Cells were harvested and lysed in 50 mM
HEPES (pH 7.4), 300 mM NaCl, 1% (v/v) b-mercaptoethanol
and 5% glycerol. The fusion protein was purified by affinity
chromatography on Ni
2+-charged chelating sepharose resin, and
the tag was removed by cleavage with thrombin, leaving a Gly-
Ser-His-Met N-terminal extension. The cleaved protein was
additionally purified using size-exclusion chromatography using
HPLC buffer (10 mM HEPES, 50 mM NaCl, 1 mM DTT,
pH 7.0). The selenomethionine-labeled protein was purified in a
similar manner.
Anti-Yer067w specific antibody
Two rabbits were immunized with purified recombinant full-
length protein Yer067w (0.12 mg) emulsified in complete Freud’s
adjuvant (Sigma) and injected subcutaneously at multiple sites on
their backs. Two weeks later, this procedure was repeated using
incomplete Freud’s adjuvant (Sigma). The immunization program
was completed with an intramuscular injection. The serum from
rabbits bled one month after the last booster was checked against
the Yer067w antigen by dot blot analysis.
Figure 8. Protein structures that share some similarity to
Yer067w according to DALI and SSM searches. The partially
aligned b-strands and a-helices are shown in blue and red, respectively.
Insertions are shown in gray. Note that most of the superimpositions
are driven by the b-strands. Protein description and homology scores
are as follows: (A)11V-161NYer067w structure, PDB: 3bcy; (B) Unknown
function protein PA94 from Pseudomonas aeruginosa, PDB: 1tu1, Z
score: 5.9, Q score: 0.17; (C) NTF-like Bal32a from a Soil-Derived Mobile
Gene Cassette, PDB: 1tuh, Z score: 3.2, Q score: 0.12; (D) NTF2-like
protein of unknown function from Burkholderia xenovorans, PDB: 3en8,
Z score: 4.3, Q score: 0.16, (E) PsbP protein in the Oxygen-Evolving
Complex of Photosystem II from higher plants, PDB: 1v2b, Z score: 5.7,
Q score: 0.11; (F) Adenovirus major late promoter TATA box-binding
protein, PDB: 1qna, Z score: 1.8, Qscore: 0.041. For comparison,
molecular modeling structures of Yer067w homologs are also shown:
(G) DEHA0D4532 model, Z score: 26.2, Q score: 0.87. (H) Yil057c model,
Z score: 28.5, Q score: 1.
doi:10.1371/journal.pone.0011163.g008
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and immunofluorescence microscopy
Yeast cells BY4741 grown in YP glycerol were collected by
centrifugation and washed twice with cold water. The cell pellets were
suspended in 500 mL SEM buffer (20 mM MES, 1 mM PMSF,
1m ME G T A ,2m MM g C l 2, 0.6 M Sorbitol, pH 6.0) supplemented
with protease inhibitors cocktail (10 mg/mL each of pepstatin,
leupeptin, aprotinin and 1 mM PMSF). Cells were disrupted using
glass beads by vortexing in 10 bursts over 1 min and cooling on ice
between bursts. The extract was clarified by centrifugation at 1000 g
during 10 minutes at 4uC. A 100 mL sample of the total protein extract
was collected (Tot), and the remaining 400 mL was centrifuged at
12,000 g for 20 minutes at 4uC. The resulting pellet was suspended in
400 mL SEM (P1), and the supernatant further centrifuged at
100,000 g for 40 minutes at 4uC. The 100,000 g pellet, enriched in
plasma membrane-bound proteins, was suspended in 400 mLS E M
(P2), and the supernatant was collected as the soluble protein fraction
(Snt). The same volume of each fractioning step was used for western
blot analysis, performed as described above. The following antibodies
were used: anti-Yer067w 1:2,000 (this work), anti-Act1 1:500 (Santa
Cruz Biotechnology), anti-Pma1 and anti-Pdr5 1:10,000 (kindly
provided by Dr. Michel Ghislain, Universite ´ Catholique Louvain la
Neuve).
Yer067w localization by indirect immunofluorescence micros-
copy was performed as described [52]. Anti Yer067w 1:50 serum
was pre-adsorbed in 1% BYDyer067w acetone powder and
incubated for 2 hours with the fixed BY4741 and BYDyer067w
cells. ALEXA fluor 488-conjugated anti-rabbit (Molecular
Probes) was diluted 1:1000 and incubated for one hour.
Fluorescent labeling was analyzed on an Axiophot microscope
(Zeiss).
11V-161NYer067w Crystallization
Initial crystallization conditions were identified by means of
hanging drop vapor diffusion using sparse matrix screens
(QIAGEN). The best crystals were obtained by equilibrating a
1.5 mL drop of a protein (6 mg/mL) in buffer (10 mM HEPES,
50 mM NaCl, 1 mM DTT, pH 7.0), mixed with 1.5 mLo f
reservoir solution containing 13% (w/v) PEG 6000, 0.2 M
ammonium chloride, 20% glycerol, and 0.1 M sodium acetate
(pH 5.0) and suspended over 1 mL of reservoir solution. Crystals
grew over 3–14 days at 20uC. For data collection, crystals were
picked up in a nylon loop and flash cooled in an N2 cold stream
(Oxford Cryosystem). The crystals contained one molecule in the
asymmetric unit (Z =8) corresponding to Vm =2.15 A ˚ 3 Da
21
and a solvent content of 42.8% [53].
11V-161NYer067w structure solution and refinement
Diffraction data from a SeMet-labeled crystal of Yer067w were
collected using a four-wavelength MAD regime on an ADSC
Quantum-210 CCD detector (Area Detector Systems Corp.) at
beamline F2 at the Cornell High-Energy Synchrotron Source
(CHESS) (Table 1). Data processing and scaling were performed
with HKL2000 [54]. The structure was determined by MAD
phasing using the program SHELX [55]. Density modification
with the program ARP/wARP [56] allowed for automated model
building of .90% of the residues.
The partial model obtained from ARP/wARP was extended
manually with the help of the program Xfit [57] and was improved
by several cycles of refinement, using the program REFMAC [58]
and model refitting, followed by the translation-libration-screw (TLS)
refinement [59]. Out of 155 residues of the construct, the final model
does not include the 9 N-terminal residues including the GSHM
cloning artifact. In addition, 155 water molecules were included in
themodel.Thefinalmodelhasgoodstereochemistry,withnooutliers
in the Ramachandran plot computed using PROCHECK [60].
Coordinates have been deposited in the RCSB Protein Data Bank
with accession code 3bcy.
Molecular modeling of Yer067w protein sequence
homologs
Tridimensional models of Yil057c and DEHA0D04532 were
generated by the program SwissModel using Yer067w structure
as the template [61]. The final energy for the Yil057c and
DEHA0D04532 model was 25826.193 kJ/mol and 25206.979 kJ/
mol, respectively.
Supporting Information
Figure S1 Phylogenetic analysis of Yer067w protein family.
The evolutionary profile of Yer067w family was inferred using
the Neighbor-Joining method, and the bootstrap consensus tree
was generated from 500 replicates (Saitou et al, 1987).
Evolutionary distances were computed using the Poisson
correction method. All positions containing gaps and missing
data were eliminated from the dataset (Complete deletion option).
There were a total of 155 positions in the final dataset.
Phylogenetic analysis was conducted in MEGA4 (Tamura et al,
2007).The percentage of replicate trees in which the associated
taxa clustered together in the bootstrap test is shown next to the
branches. The tree is drawn to scale, with branch lengths in the
same units as those of the evolutionary distances used to infer the
phylogenetic tree. Cluster (a) contains organisms that translate
GTC as serine instead of leucine. Cluster (b) is formed by proteins
from species that diverged before (branch c) and after the whole
genome duplication event. The species and gene notation follows
the code described in Fig. 1.
Found at: doi:10.1371/journal.pone.0011163.s001 (2.86 MB
TIF)
Figure S2 Overlay of the 2D [15N,1H]-HSQC spectra of the
15N-labeled full-length Yer067w (cyan contours) and the truncat-
ed 11V161NYer067w (red contours). Almost all dispersed peaks of
11V161NYer067w are perfectly superposed to the full-length
protein, a strong indication that the overall fold is preserved in
the shortened version.
Found at: doi:10.1371/journal.pone.0011163.s002 (0.05 MB
PDF)
Table S1 Genes that share a similar transcriptional expres-
sion pattern to YER067W and YIL057C.S u m m a r yo ft h e
results retrieved from the program SPELL (http://imperio.
princeton.edu:3000/yeast). This program identifies which
microarray datasets are most informative for the query gene.
Genes with expression profiles similar to the query are
identified within these datasets. The YER067W and YIL057C
expression profiles were compared against approximately 100
microarray experiments.
Found at: doi:10.1371/journal.pone.0011163.s003 (0.03 MB
PDF)
Table S2 Transcriptional factor binding motifs present in
YER067W and YIL057C promoters. These data refer to the
predicted putative binding sites with indirect or direct experimen-
tal evidence. Data were generated by the YeastStract server
(http://www.yeastract.com).
Found at: doi:10.1371/journal.pone.0011163.s004 (0.04 MB
PDF)
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